VivoSim Labs
VIVS
102 hedge funds and large institutions have $143M invested in VivoSim Labs in 2014 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 31 increasing their positions, 20 reducing their positions, and 15 closing their positions.
55% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 20
40% more capital invested
Capital invested by funds: $102M → $143M (+$40.6M)
20% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 15
2% more funds holding
Funds holding: 100 → 102 (+2)
0.02% more ownership
Funds ownership: 0.09% → 0.1% (+0.02%)
31% less call options, than puts
Call options by funds: $7.73M | Put options by funds: $11.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$3.75M |
| 2 |
Tiger Global Management
New York
|
+$3.2M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.35M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$2.16M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.57M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.19M |
| 2 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$559K |
| 3 |
Millennium Management
New York
|
-$423K |
| 4 |
ABI
Adamant Biomedical Investments
Zurich,
Switzerland
|
-$319K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$309K |
VIVS Hedge Fund Activity: Q4 2014 in Review
102 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q4 2014, worth a combined $143M — up 40% from $102M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new VIVS positions and 15 closed out — a net gain of 3 holders — while 31 added to existing stakes and 20 trimmed.
The largest buyer was State Street, adding an estimated $3.75M. The largest seller was Fidelity Investments, cutting an estimated $2.19M.
- 102 institutional investors held VivoSim Labs (VIVS) as of Q4 2014, up from 100 in Q3 2014.
- Funds reported $143M of VivoSim Labs stock for Q4 2014, up 40% quarter-over-quarter.
- 18 funds opened new VivoSim Labs positions in Q4 2014 and 15 closed out, a net change of +3 holders.
- The largest VivoSim Labs buyer in Q4 2014 was State Street, an estimated $3.75M added.
- The largest VivoSim Labs seller in Q4 2014 was Fidelity Investments, an estimated $2.19M sold.
Based on aggregated 13F filings for Q4 2014.